Comerica Bank’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-241
Closed -$7.72K 3692
2024
Q3
$7.72K Sell
241
-28
-10% -$1.55K ﹤0.01% 3236
2024
Q2
$22.1K Hold
269
﹤0.01% 2970
2024
Q1
$39K Hold
269
﹤0.01% 2827
2023
Q4
$24.8K Buy
269
+24
+10% +$2.44K ﹤0.01% 2921
2023
Q3
$40.4K Buy
+245
New +$31.8K ﹤0.01% 2768

Other funds holding CDLX

Comerica Bank's CDLX Position: Q4 2024 in Review

Comerica Bank sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 241 shares — an estimated $7.72K sold.

Comerica Bank first reported a position in CDLX in Q3 2023 and held it in 5 quarters. The position peaked at $40.4K in Q3 2023. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Comerica Bank reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Comerica Bank sold 241 Cardlytics shares in Q4 2024, an estimated $7.72K.
  • Comerica Bank first reported a position in Cardlytics in Q3 2023 and held it in 5 quarters.
  • Comerica Bank's Cardlytics position peaked at $40.4K in Q3 2023.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.